N
Nathan J. Marchant
Researcher at VU University Medical Center
Publications - 39
Citations - 2893
Nathan J. Marchant is an academic researcher from VU University Medical Center. The author has contributed to research in topics: Abstinence & Nucleus accumbens. The author has an hindex of 27, co-authored 38 publications receiving 2436 citations. Previous affiliations of Nathan J. Marchant include Vanderbilt University Medical Center & Royal North Shore Hospital.
Papers
More filters
Journal ArticleDOI
The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research
TL;DR: The ventral subiculum and lateral hypothalamus are highlighted as emerging brain areas important for reinstatement of drug seeking across drug classes and the existence of differences in brain mechanisms controlling reinstatement in drug seeking is highlighted.
Journal ArticleDOI
Role of Projections from Ventral Medial Prefrontal Cortex to Nucleus Accumbens Shell in Context-Induced Reinstatement of Heroin Seeking
Jennifer M. Bossert,Anna L. Stern,Florence R. M. Theberge,Nathan J. Marchant,Hui Ling Wang,Marisela Morales,Yavin Shaham +6 more
TL;DR: It is demonstrated that activation of glutamatergic projections from ventral mPFC to accumbens shell, previously implicated in inhibition of cocaine relapse, promotes heroin relapse.
Journal ArticleDOI
Recent developments in animal models of drug relapse
TL;DR: This review introduces and discusses recent findings from several other relapse models, including incubation of drug craving, reacquisition and resurgence models, and punishment-based and conflict-based relapse models.
Journal ArticleDOI
The Anterior Insular Cortex→Central Amygdala Glutamatergic Pathway Is Critical to Relapse after Contingency Management
Marco Venniro,Daniele Caprioli,Michelle Zhang,Leslie R. Whitaker,Shiliang Zhang,Brandon L. Warren,Carlo Cifani,Nathan J. Marchant,Ofer Yizhar,Jennifer M. Bossert,Cristiano Chiamulera,Marisela Morales,Yavin Shaham +12 more
TL;DR: A novel rat model is used, in which the availability of a mutually exclusive palatable food maintains prolonged voluntary abstinence from intravenous methamphetamine self-administration, to demonstrate that the activation of monosynaptic glutamatergic projections from anterior insular cortex to central amygdala is critical to relapse after the cessation of contingency management.
Journal ArticleDOI
Effect of the Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 2 AZD8529 on Incubation of Methamphetamine Craving After Prolonged Voluntary Abstinence in a Rat Model.
Daniele Caprioli,Marco Venniro,Tamara Zeric,Xuan Li,Sweta Adhikary,Rajtarun Madangopal,Nathan J. Marchant,Federica Lucantonio,Geoffrey Schoenbaum,Jennifer M. Bossert,Yavin Shaham +10 more
TL;DR: A novel animal model is introduced to study incubation of drug craving and cue-induced drug seeking after prolonged voluntary abstinence, mimicking the human condition of relapse after successful contingency management treatment, and positive allosteric modulators of metabotropic glutamate receptor 2 should be considered for relapse prevention.